CBLL Stock Summary and Trading Ideas (Ceribell | NASDAQ:CBLL)

CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.

Ceribell trades on the NASDAQ stock market under the symbol CBLL.

As of October 2, 2026, CBLL stock price climbed to $23.69 with 293,367 million shares trading.

CBLL has a beta of 0.85, meaning it tends to be less sensitive to market movements. CBLL has a correlation of 0.04 to the broad based SPY ETF.

CBLL has a market cap of $909.18 million. This is considered a Small Cap stock.

Last quarter Ceribell reported $28 million in Revenue and -$.51 earnings per share. This beat revenue expectation by $828,576 and missed earnings estimates by -$.05.

The top ETF exchange traded funds that CBLL belongs to (by Net Assets): VTI, IWM, IWO, VXF, VTWO.

CBLL has outperformed the market in the last year with a return of +100.6%, while the SPY ETF gained +16.1%. In the last 3 month period, CBLL beat the market returning +21.2%, while SPY returned +3.6%. However, in the most recent 2 weeks CBLL has underperformed the stock market by returning -2.8%, while SPY returned +1.0%.

CBLL support price is $23.03 and resistance is $24.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBLL shares will trade within this expected range on the day.